![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | RGD:1553296 | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of OS9 mRNA | CTD | PMID:36331819 | 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | multiple interactions | EXP | | 6480464 | 2 more ... | CTD | PMID:19414516 | 1,2-dimethylhydrazine | increases expression | ISO | RGD:1553296 | 6480464 | 1, 2-Dimethylhydrazine results in increased expression of OS9 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | affects expression | ISO | RGD:1553296 | 6480464 | Ethinyl Estradiol affects the expression of OS9 mRNA | CTD | PMID:17555576 | 17beta-estradiol | decreases expression | ISO | RGD:1553296 | 6480464 | Estradiol results in decreased expression of OS9 mRNA | CTD | PMID:19484750 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1553296 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of OS9 mRNA | CTD | PMID:19465110 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1553296 | 6480464 | Tetrachlorodibenzodioxin affects the expression of OS9 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of OS9 mRNA | CTD | PMID:21215274 | 2,3-dimethoxynaphthalene-1,4-dione | decreases expression | ISO | RGD:1605693 | 6480464 | 2 more ... | CTD | PMID:17547211 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2, 4-dinitrotoluene affects the expression of OS9 mRNA | CTD | PMID:21346803 | 3',5'-cyclic AMP | multiple interactions | EXP | | 6480464 | 2 more ... | CTD | PMID:19414516 | 3-chloropropane-1,2-diol | increases expression | EXP | | 6480464 | alpha-Chlorohydrin results in increased expression of OS9 protein | CTD | PMID:34915118 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1605693 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of OS9 mRNA | CTD | PMID:28628672 | acrolein | multiple interactions | ISO | RGD:1605693 | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of OS9 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of OS9 mRNA | CTD | PMID:32699268 | aflatoxin B1 | decreases expression | ISO | RGD:1553296 | 6480464 | Aflatoxin B1 results in decreased expression of OS9 mRNA | CTD | PMID:19770486 | all-trans-retinoic acid | multiple interactions | ISO | RGD:1605693 | 6480464 | [Tretinoin co-treated with Ascorbic Acid] results in decreased expression of OS9 mRNA | CTD | PMID:16443354 | all-trans-retinoic acid | increases expression | ISO | RGD:1605693 | 6480464 | Tretinoin results in increased expression of OS9 mRNA | CTD | PMID:33167477 | alpha-pinene | multiple interactions | ISO | RGD:1605693 | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of OS9 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of OS9 mRNA | CTD | PMID:32699268 | antimony(0) | decreases expression | ISO | RGD:1605693 | 6480464 | Antimony results in decreased expression of OS9 mRNA | CTD | PMID:17547211 | arsenous acid | decreases expression | ISO | RGD:1605693 | 6480464 | Arsenic Trioxide results in decreased expression of OS9 mRNA | CTD | PMID:17547211 | Benoxacor | decreases expression | ISO | RGD:1553296 | 6480464 | benoxacor results in decreased expression of OS9 mRNA | CTD | PMID:34850242 | benzo[a]pyrene | affects methylation | ISO | RGD:1605693 | 6480464 | Benzo(a)pyrene affects the methylation of OS9 promoter | CTD | PMID:27901495 | benzo[a]pyrene | decreases methylation | ISO | RGD:1553296 | 6480464 | Benzo(a)pyrene results in decreased methylation of OS9 exon, Benzo(a)pyrene results in decreased methylation of OS9 intron | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | ISO | RGD:1605693 | 6480464 | Benzo(a)pyrene results in increased methylation of OS9 exon | CTD | PMID:27901495 | bisphenol A | increases expression | ISO | RGD:1605693 | 6480464 | bisphenol A results in increased expression of OS9 mRNA | CTD | PMID:20678512 | bisphenol A | decreases expression | ISO | RGD:1605693 | 6480464 | bisphenol A results in decreased expression of OS9 protein | CTD | PMID:34186270 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of OS9 mRNA | CTD | PMID:34947998 | bisphenol A | increases methylation | ISO | RGD:1605693 | 6480464 | bisphenol A results in increased methylation of OS9 gene | CTD | PMID:31601247 | bisphenol A | multiple interactions | ISO | RGD:1605693 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of OS9 mRNA | CTD | PMID:28628672 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of OS9 mRNA | CTD | PMID:30816183, PMID:32528016 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of OS9 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | ISO | RGD:1553296 | 6480464 | bisphenol A results in increased expression of OS9 mRNA | CTD | PMID:26063408 | bortezomib | increases expression | ISO | RGD:1605693 | 6480464 | Bortezomib results in increased expression of OS9 mRNA | CTD | PMID:20977926 | cadmium atom | decreases expression | ISO | RGD:1605693 | 6480464 | Cadmium results in decreased expression of OS9 mRNA | CTD | PMID:17547211 | cadmium dichloride | decreases expression | ISO | RGD:1605693 | 6480464 | Cadmium Chloride results in decreased expression of OS9 mRNA | CTD | PMID:17547211 | chromium atom | decreases expression | ISO | RGD:1605693 | 6480464 | Chromium results in decreased expression of OS9 mRNA | CTD | PMID:17547211 | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of OS9 mRNA | CTD | PMID:33631298 | cisplatin | multiple interactions | EXP | | 6480464 | ursodoxicoltaurine inhibits the reaction [Cisplatin results in increased expression of OS9 mRNA] | CTD | PMID:33631298 | clofibrate | decreases expression | ISO | RGD:1553296 | 6480464 | Clofibrate results in decreased expression of OS9 mRNA | CTD | PMID:17585979 | clofibrate | multiple interactions | ISO | RGD:1553296 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of OS9 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of OS9 mRNA] | CTD | PMID:17585979 | crocidolite asbestos | decreases methylation | ISO | RGD:1605693 | 6480464 | Asbestos, Crocidolite results in decreased methylation of OS9 3' UTR | CTD | PMID:29523930 | dexamethasone | multiple interactions | ISO | RGD:1605693 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of OS9 mRNA | CTD | PMID:28628672 | diarsenic trioxide | decreases expression | ISO | RGD:1605693 | 6480464 | Arsenic Trioxide results in decreased expression of OS9 mRNA | CTD | PMID:17547211 | dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate | decreases expression | ISO | RGD:1605693 | 6480464 | Antimony Potassium Tartrate results in decreased expression of OS9 mRNA | CTD | PMID:17547211 | elemental selenium | increases expression | ISO | RGD:1605693 | 6480464 | Selenium results in increased expression of OS9 mRNA | CTD | PMID:19244175 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of OS9 mRNA | CTD | PMID:31464424 | ethanol | increases expression | ISO | RGD:1553296 | 6480464 | Ethanol results in increased expression of OS9 mRNA | CTD | PMID:30319688 | ethanol | multiple interactions | ISO | RGD:1553296 | 6480464 | Ethanol affects the expression of and affects the splicing of OS9 mRNA | CTD | PMID:30319688 | gold atom | multiple interactions | ISO | RGD:1605693 | 6480464 | [Polyethyleneimine binds to Gold] which results in decreased expression of OS9 mRNA | CTD | PMID:28433809 | gold(0) | multiple interactions | ISO | RGD:1605693 | 6480464 | [Polyethyleneimine binds to Gold] which results in decreased expression of OS9 mRNA | CTD | PMID:28433809 | indometacin | multiple interactions | ISO | RGD:1605693 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of OS9 mRNA | CTD | PMID:28628672 | inulin | multiple interactions | ISO | RGD:1553296 | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of OS9 mRNA | CTD | PMID:36331819 | L-ascorbic acid | multiple interactions | ISO | RGD:1605693 | 6480464 | [Tretinoin co-treated with Ascorbic Acid] results in decreased expression of OS9 mRNA | CTD | PMID:16443354 | lead(0) | affects splicing | ISO | RGD:1605693 | 6480464 | Lead affects the splicing of OS9 mRNA | CTD | PMID:28903495 | lead(2+) | affects splicing | ISO | RGD:1605693 | 6480464 | Lead affects the splicing of OS9 mRNA | CTD | PMID:28903495 | mercury atom | decreases expression | ISO | RGD:1605693 | 6480464 | Mercury results in decreased expression of OS9 mRNA | CTD | PMID:17547211 | mercury(0) | decreases expression | ISO | RGD:1605693 | 6480464 | Mercury results in decreased expression of OS9 mRNA | CTD | PMID:17547211 | ozone | multiple interactions | ISO | RGD:1605693 | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of OS9 mRNA more ... | CTD | PMID:32699268 | paracetamol | multiple interactions | ISO | RGD:1553296 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of OS9 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of OS9 mRNA] | CTD | PMID:17585979 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | RGD:1553296 | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of OS9 mRNA, [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of OS9 mRNA | CTD | PMID:36331819 | pirinixic acid | decreases expression | ISO | RGD:1553296 | 6480464 | pirinixic acid results in decreased expression of OS9 mRNA | CTD | PMID:23811191 | potassium dichromate | decreases expression | ISO | RGD:1605693 | 6480464 | Potassium Dichromate results in decreased expression of OS9 mRNA | CTD | PMID:17547211 | selenium atom | increases expression | ISO | RGD:1605693 | 6480464 | Selenium results in increased expression of OS9 mRNA | CTD | PMID:19244175 | tamoxifen | affects expression | ISO | RGD:1553296 | 6480464 | Tamoxifen affects the expression of OS9 mRNA | CTD | PMID:17555576 | tauroursodeoxycholic acid | multiple interactions | EXP | | 6480464 | ursodoxicoltaurine inhibits the reaction [Cisplatin results in increased expression of OS9 mRNA] | CTD | PMID:33631298 | tert-butyl hydroperoxide | decreases expression | ISO | RGD:1605693 | 6480464 | tert-Butylhydroperoxide results in decreased expression of OS9 mRNA | CTD | PMID:15336504 | thapsigargin | increases expression | ISO | RGD:1605693 | 6480464 | Thapsigargin results in increased expression of OS9 mRNA | CTD | PMID:22378314 | thapsigargin | increases expression | EXP | | 6480464 | Thapsigargin results in increased expression of OS9 protein | CTD | PMID:35544339 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of OS9 mRNA | CTD | PMID:34492290 | tungsten | decreases expression | ISO | RGD:1553296 | 6480464 | Tungsten results in decreased expression of OS9 mRNA | CTD | PMID:30912803 | tunicamycin | increases expression | ISO | RGD:1605693 | 6480464 | Tunicamycin results in increased expression of OS9 mRNA | CTD | PMID:22378314 | urethane | increases expression | ISO | RGD:1605693 | 6480464 | Urethane results in increased expression of OS9 mRNA | CTD | PMID:28818685 | valproic acid | increases expression | ISO | RGD:1605693 | 6480464 | Valproic Acid results in increased expression of OS9 mRNA | CTD | PMID:23179753 | valproic acid | decreases methylation | ISO | RGD:1605693 | 6480464 | Valproic Acid results in decreased methylation of OS9 gene | CTD | PMID:29154799 | valproic acid | affects expression | ISO | RGD:1605693 | 6480464 | Valproic Acid affects the expression of OS9 mRNA | CTD | PMID:25979313 | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of OS9 mRNA | CTD | PMID:23034163 | vitamin E | increases expression | ISO | RGD:1605693 | 6480464 | Vitamin E results in increased expression of OS9 mRNA | CTD | PMID:19244175 | |